Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to TamoxifenI‐Chun Chen, Yen‐Shen Lu|Scientific Reports|2017Cited by 33